Atai Beckley N.V. (NASDAQ:ATAI) is considered one of the Best Get Rich Fast Stocks to Buy Right Now. Analyst Justin Walsh initiated coverage with a ‘Buy’ rating and a price target of $16, suggesting a nearly 282% upside potential. The company focuses on psychedelic and empathogenic drugs for neuropsychiatric indications.

JonesTrading sees potential for Atai Beckley N.V. (NASDAQ:ATAI) in the treatment-resistant depression market, especially with the short half-lives of their drugs. The approval of a new patent for EMP-01, an oral R-MDMA solution for social anxiety disorder, reinforces the company’s commitment to innovation and patient outcomes.

Atai Beckley N.V. (NASDAQ:ATAI) is a clinical-stage biopharmaceutical company based in the Netherlands, specializing in mental health treatments. While the company shows promise as an investment, there may be AI stocks with greater upside potential and less downside risk. Explore our report on the best short-term AI stock for more insights.

Read more at Yahoo Finance: JonesTrading Highlights Differentiated Pipeline at Atai Beckley N.V. (ATAI)